FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292185755> ?p ?o ?g. }

• W4292185755 abstract "Abstract Background Chronic obstructive pulmonary disease (COPD) and interstital lung disease (ILD) are incurable conditions characterised by airflow limitation, persisting respiratory symptoms, and progressive respiratory failure. People living with COPD or ILD often suffer from chronic and severe breathlessness, with limited treatment options and low engagement rates with current therapies. Group singing represents a potential community-based therapy to improve quality of life for patients with COPD or ILD and breathlessness. Methods This protocol papers describes SINFONIA, a parallel, double-arm, randomised, blinded-analysis, mixed-methods phase II/III trial of guided, online group singing that will be conducted over 24 months. Adults with confirmed COPD or ILD, on stable treatment for at least four weeks at time of recruitment, with a modified Medical Research Council (mMRC) dyspnoea score of two or greater, who are capable and willing to give consent, and not currently participating in pulmonary rehabilitation will be eligible to participate. Carers may optionally enrol in the trial. Data will be collected on quality of life, anxiety and depression, breathlessness, mastery of breathing, exercise tolerance, loneliness, healthcare utilisation, and carer quality of life (optional). Participants will be randomised 1:1 to intervention or control arms with intervention arm attending one 90 min, guided, online, group singing session per week for 12 weeks and control arm continuing routine care. Phase II of the trial aims to determine the feasibility and acceptability of guided, online group singing and will collect preliminary data on effectiveness. Phase III aims to determine whether guided, online group singing has an effect on quality of life with the primary outcome being a between arm difference in quality of life (36-item Short Form Survey) measured at 12 weeks. Discussion SINFONIA is the first study is the first of its kind in Australia and to our knowledge, the first to deliver the singing intervention program entirely online. Determining the feasibility, acceptability, and effectiveness of guided, online group singing is an important step towards improving low-cost, low-risk, community-based therapeutic options for patients living with COPD or ILD and breathlessness. Trial registration: Phase II— ACTRN12621001274864 , registered 20th September 2021; Phase III— ACTRN12621001280897 , registered 22nd September 2021." @default.
• W4292185755 created "2022-08-18" @default.
• W4292185755 creator A5008724107 @default.
• W4292185755 creator A5014009372 @default.
• W4292185755 creator A5028538552 @default.
• W4292185755 creator A5028884287 @default.
• W4292185755 date "2022-08-16" @default.
• W4292185755 modified "2023-09-25" @default.
• W4292185755 title "SINFONIA study protocol: a phase II/III randomised controlled trial examining benefits of guided online group singing in people with chronic obstructive pulmonary disease and interstitial lung disease and their carers" @default.
• W4292185755 cites W1845447069 @default.
• W4292185755 cites W1967924979 @default.
• W4292185755 cites W1974431577 @default.
• W4292185755 cites W1979290264 @default.
• W4292185755 cites W2002057781 @default.
• W4292185755 cites W2006331513 @default.
• W4292185755 cites W2022584773 @default.
• W4292185755 cites W2035262623 @default.
• W4292185755 cites W2039828641 @default.
• W4292185755 cites W2055113240 @default.
• W4292185755 cites W2071782474 @default.
• W4292185755 cites W2078873372 @default.
• W4292185755 cites W2080511042 @default.
• W4292185755 cites W2080863293 @default.
• W4292185755 cites W2086148078 @default.
• W4292185755 cites W2088779664 @default.
• W4292185755 cites W2096312526 @default.
• W4292185755 cites W2097667004 @default.
• W4292185755 cites W2101443745 @default.
• W4292185755 cites W2117152544 @default.
• W4292185755 cites W2122570705 @default.
• W4292185755 cites W2139347600 @default.
• W4292185755 cites W2156523739 @default.
• W4292185755 cites W2157461485 @default.
• W4292185755 cites W2166023752 @default.
• W4292185755 cites W2166281097 @default.
• W4292185755 cites W2171811563 @default.
• W4292185755 cites W2305278139 @default.
• W4292185755 cites W2371855066 @default.
• W4292185755 cites W2495786184 @default.
• W4292185755 cites W2521794462 @default.
• W4292185755 cites W2530205141 @default.
• W4292185755 cites W2559690057 @default.
• W4292185755 cites W2580449460 @default.
• W4292185755 cites W2736734957 @default.
• W4292185755 cites W2796372689 @default.
• W4292185755 cites W2804150565 @default.
• W4292185755 cites W2885705243 @default.
• W4292185755 cites W2901478545 @default.
• W4292185755 cites W2908467008 @default.
• W4292185755 cites W3007089614 @default.
• W4292185755 cites W3017340620 @default.
• W4292185755 cites W3087688900 @default.
• W4292185755 cites W3105964792 @default.
• W4292185755 cites W3107709374 @default.
• W4292185755 cites W4211009571 @default.
• W4292185755 cites W4225015613 @default.
• W4292185755 doi "https://doi.org/10.1186/s12931-022-02133-3" @default.
• W4292185755 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35974347" @default.
• W4292185755 hasPublicationYear "2022" @default.
• W4292185755 type Work @default.
• W4292185755 citedByCount "1" @default.
• W4292185755 countsByYear W42921857552023 @default.
• W4292185755 crossrefType "journal-article" @default.
• W4292185755 hasAuthorship W4292185755A5008724107 @default.
• W4292185755 hasAuthorship W4292185755A5014009372 @default.
• W4292185755 hasAuthorship W4292185755A5028538552 @default.
• W4292185755 hasAuthorship W4292185755A5028884287 @default.
• W4292185755 hasBestOaLocation W42921857551 @default.
• W4292185755 hasConcept C118552586 @default.
• W4292185755 hasConcept C126322002 @default.
• W4292185755 hasConcept C139719470 @default.
• W4292185755 hasConcept C159110408 @default.
• W4292185755 hasConcept C162324750 @default.
• W4292185755 hasConcept C168563851 @default.
• W4292185755 hasConcept C1862650 @default.
• W4292185755 hasConcept C187736073 @default.
• W4292185755 hasConcept C2776780178 @default.
• W4292185755 hasConcept C2776867660 @default.
• W4292185755 hasConcept C2777543607 @default.
• W4292185755 hasConcept C2777714996 @default.
• W4292185755 hasConcept C2778818304 @default.
• W4292185755 hasConcept C2779951463 @default.
• W4292185755 hasConcept C2780779891 @default.
• W4292185755 hasConcept C44819458 @default.
• W4292185755 hasConcept C535046627 @default.
• W4292185755 hasConcept C558461103 @default.
• W4292185755 hasConcept C71924100 @default.
• W4292185755 hasConceptScore W4292185755C118552586 @default.
• W4292185755 hasConceptScore W4292185755C126322002 @default.
• W4292185755 hasConceptScore W4292185755C139719470 @default.
• W4292185755 hasConceptScore W4292185755C159110408 @default.
• W4292185755 hasConceptScore W4292185755C162324750 @default.
• W4292185755 hasConceptScore W4292185755C168563851 @default.
• W4292185755 hasConceptScore W4292185755C1862650 @default.
• W4292185755 hasConceptScore W4292185755C187736073 @default.
• W4292185755 hasConceptScore W4292185755C2776780178 @default.
• W4292185755 hasConceptScore W4292185755C2776867660 @default.
• W4292185755 hasConceptScore W4292185755C2777543607 @default.
• W4292185755 hasConceptScore W4292185755C2777714996 @default.
• W4292185755 hasConceptScore W4292185755C2778818304 @default.

• next